Laboratorios Farmaceuticos RoviFRA:41L -1.99%93 Days Inventory is 430.28 as of Mar. 2026, which is 29% above its 10-year median of 334.10. GuruFocus rates FRA:41L with a GF Score™ of 93/100 and a GF Value™ of €50.70 (Fairly Valued). The stock has 1 warning sign investors should review. Among 919 Drug Manufacturers companies, Laboratorios Farmaceuticos Rovi ranks worse than 93.36% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Laboratorios Farmaceuticos Rovi's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.21.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Laboratorios Farmaceuticos Rovi's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.84.
Laboratorios Farmaceuticos Rovi (FRA:41L) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Laboratorios Farmaceuticos Rovi's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Laboratorios Farmaceuticos Rovi's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Laboratorios Farmaceuticos Rovi Days Inventory Related Terms
Laboratorios Farmaceuticos Rovi Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Laboratorios Farmaceuticos Rovi Days Inventory Chart
FRA:41L vs ZTS, UTHR, VTRS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Laboratorios Farmaceuticos Rovi's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Laboratorios Farmaceuticos Rovi Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Laboratorios Farmaceuticos Rovi's Days Inventory distribution charts can be found below:
* The bar in red indicates where Laboratorios Farmaceuticos Rovi's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Laboratorios Farmaceuticos Rovi (FRA:41L) has a Days Inventory of 430.28 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Laboratorios Farmaceuticos Rovi and its competitors. This is 29% above median its historical median of 334.10. Over the past decade, Laboratorios Farmaceuticos Rovi's Days Inventory has ranged from 213.81 to 434.73. According to the industry distribution chart, Laboratorios Farmaceuticos Rovi ranks #858 out of 919 companies in the Drug Manufacturers industry, placing it in the top 93.4%.
Is Laboratorios Farmaceuticos Rovi's Days Inventory too high?
Laboratorios Farmaceuticos Rovi's current Days Inventory of 430.28 is 29% above median its 10-year median of 334.10. Over the past 10 years, this metric has ranged from a low of 213.81 to a high of 434.73. The Drug Manufacturers industry median Days Inventory is 164.48. Laboratorios Farmaceuticos Rovi's value of 430.28 is 161.6% above this industry median. Based on the distribution chart, Laboratorios Farmaceuticos Rovi ranks #858 out of 919 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Laboratorios Farmaceuticos Rovi has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Laboratorios Farmaceuticos Rovi's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Laboratorios Farmaceuticos Rovi ranks #858 out of 919 companies for Days Inventory. This places Laboratorios Farmaceuticos Rovi in the lower half of its industry. The industry median Days Inventory is 164.48. Laboratorios Farmaceuticos Rovi's value of 430.28 is 161.6% above this benchmark. Historically, Laboratorios Farmaceuticos Rovi's own Days Inventory has ranged from 213.81 to 434.73 over the past decade. While the company's 10-year median is 334.10 vs. the industry median of 164.48, Laboratorios Farmaceuticos Rovi has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Laboratorios Farmaceuticos Rovi's current Days Inventory of 430.28 is 161.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Laboratorios Farmaceuticos Rovi and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Laboratorios Farmaceuticos Rovi's current Days Inventory is 430.28, which is 29% above median its own 10-year median of 334.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laboratorios Farmaceuticos Rovi stock overvalued right now?
Based on GuruFocus' analysis, Laboratorios Farmaceuticos Rovi (FRA:41L) is currently considered Fairly Valued. The stock's GF Value™ is €50.70, compared to a current price of €56.75 — trading 11.9% above its estimated fair value. The current Days Inventory is 430.28, which is 29% above median its 10-year median of 334.10 and 161.6% above the Drug Manufacturers industry median of 164.48. Laboratorios Farmaceuticos Rovi's overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Laboratorios Farmaceuticos Rovi (FRA:41L), the current Days Inventory is 430.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Laboratorios Farmaceuticos Rovi (FRA:41L) Overvalued in 2026?
Based on GuruFocus' analysis, Laboratorios Farmaceuticos Rovi stock appears to be overvalued.
The current stock price of €56.75 is trading 11.9% above its estimated GF Value™ of €50.70.
GuruFocus considers Laboratorios Farmaceuticos Rovi to be Fairly Valued.
Key valuation signals for FRA:41L:
Days Inventory: 430.28 (29% above median its 10-year median of 334.10)
GF Value™: €50.70 vs. price of €56.75 (11.9% above fair value)
Industry Position: 161.6% above the Drug Manufacturers median (#858 of 919)
No single metric tells the full story. See the FRA:41L stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Laboratorios Farmaceuticos Rovi Business Description
Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.
93GF Score
Get the complete analysis for FRA:41L
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:41L has been successfully added to your 
